Allergan Inc

Allergan Inc
Allergan Inc
Type: Company
Name: Allergan Inc
Nationality: United States
Fact Sheet: Fact Sheet for Allergan Inc.
First reported 41 mins ago - Updated 41 mins ago - 1 reports
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd

Should These Drug Companies Pay a Dividend?

Chris is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.Even a hardcore dividend addict such as I will admit that there are times when a company should hold off on paying a ... [Published Motley Fool - 41 mins ago]
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Quinn Clinics Among First in UK to Offer New Juvéderm VOLBELLA Lip Filler Injections and Training Courses

Quinn Clinics is proud to be selected as one of the first in the UK to offer the latest Juvéderm VOLBELLA lip filler from Allergan, and has also been accredited to offer training for medical professionals in the new anti-ageing technology.Dr John Quinn ... [Published PRWeb UK - 5 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Research and Markets Adds Report: Allergan Partnering 2005-2013

Research and Markets announced the addition of the "Allergan Partnering 2005-2013" company profile to its offerings. In a release, Research and Markets noted that report highlights include:This report provides all the information you require to better ... [Published Individual.com - 13 hours ago]
First reported May 22 2013 - Updated May 22 2013 - 1 reports
FDA Food & Drug Administration
FDA Food & Drug Administration

Pro Te Solutio - Vol. 6 No. 1 February 2013

- Can Experts Testify as to the Ethics or State of Mind of Corporate Defendants?- Patent Reform for Biotech Companies- United States v. Caronia and its Implications for Off-Label Marketing of Pharmaceuticals- Excerpt from Can Experts Testify as to the ... [Published JD Supra - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Colorescience Appoints Steve Loomis Chief Financial Officer

/PRNewswire/ -- Colorescience today announced the appointment of Steve P. Loomis as Chief Financial Officer, further expanding the brand's executive team. Sponsored by: "I am delighted to welcome Steve to Colorescience after working with him at SkinMedica ... [Published TickerTech.com - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports
Allergan Inc
Allergan Inc

Allergan (AGN) Showing Bearish Technicals But Could Break Through $100.47 Resistance

Allergan Inc. (NYSE: AGN) closed Tuesday's trading session at $98.54. In the past year, the stock has hit a 52-week low of $81.28 and 52-week high of $116.45. Allergan (AGN) stock has been showing support around $96.89 and resistance in the $100.47 range. ... [Published MarketIntelligenceCenter.com - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

MediFocus: Medical Devices for the Treatment of Obesity

Global obesity medical devices market: Significant industry changes expected in coming years The obesity medical device market is expected to experience significant change in the near future, as new products come to market, older products see a decline ... [Published companiesandmarkets.com - May 22 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Susan G. Komen Orange County’s Pink Tie Ball Raises Nearly $400,000 for Breast Cancer

- TUSTIN, Calif. -- ’s (http://www.komenoc.org/) annual once again proved to be a stirring event dedicated to raising awareness and funds for breast cancer. Held on the lake and under the stars this year at picturesque Lake Mission Viejo, the May 11 gala ... [Published Prlog - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Top 10 Biotech CEO Pay Packages of 2012

It's a great time to helm a large biotech company, generally. Big biotech players overall posted major growth last year, and their CEOs got richer in the process. Most got fat raises while others saw their bundles of pay pale in comparison to 2011 fi ... [Published FierceBiotech - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Local Doctors Get Big Bucks from Big Pharma

When you get a prescription from your doctor, you probably don't think to ask if he or she is ever on the drug company's dime. But maybe you should.NBC Connecticut and investigative newsroom ProPublica uncovered millions of dollars that Big Pharma shelled ... [Published NBC Connecticut - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

News Review: Allergan, Inc. (NYSE:AGN), Infinera Corp, VMware, Inc. (NYSE:VMW), QLogic Corporation

Austin, TX -- ( SBWIRE ) -- 05/21/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-Allergan, Inc. ... [Published SBWire - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Allergan, Mentor and Galderma Lead the Accelerating European Market...

Increasing demand for affordable, minimally invasive products and name-brand recognition is driving cosmetic device sales in Europe, particularly the botulinum toxin A market. According to a new report series by iData Research, the total European market ... [Published PRWeb - May 21 2013]

Quotes

...and we are pleased to deliver some of the newest rental options in highly desirable apartment markets," said Michael Genthe, Managing Director. "Our focus on prime locations in supply constrained markets provides our residents with easy access to key employers, shopping and entertainment districts. Our development expertise allows us to deliver an unparalleled features and amenities package designed to appeal to today's savvy renter. We look forward to growing our presence in the SouthernSouthern California market and are actively seeking more sites."
Mill Creek Residential Breaks Ground on Three Multifamily Co. . . [Published Equities.com - 17 hours ago]
In his first year at SkinMedica, Mr. Loomis, was named "San Diego "I'm excited to join an all-star team at Colorescience and be part of aggressively growing this extraordinary business," said Mr. Loomis.$ "I was impressed with the team and business opportunity when we bought Colorescience eighteen months ago, and am now looking forward to working toward replicating the success we experienced at SkinMedica.""
Colorescience Appoints Steve Loomis Chief Financial Officer [Published KCTV 5 - May 22 2013]
...Experts like Dr. Ross said while physicians may think the money doesn't matter, evidence shows otherwise. "Decades of research have shown that these payments and other promotional marketing objectives from the companies are effective at influencing prescribing behavior, said Dr. Ross. Taxpayer dollars may be at stake. In 2010 and 2011, state records show Dr. Michael Brennan of Fairfield was the state's top Medicaid prescriber of pain medicine Actiq. Two years ago he wrote more than double the amount of Actiq prescriptions than the next highest prescriber. Over the course of 4 years drug company Cephalon, maker of Actiq, paid him $50,000 in speaking, consulting, and travel. Dr. Brennan said he's prescribed Actiq "in relatively infrequent cases, and in a written statement told the Troubleshooters"
Local Doctors Get Big Bucks from Big Pharma [Published NBC Connecticut - May 21 2013]
"We will launch it in Chengdu no later than the first half of 2014, probably starting from one department before it is widely adopted" he said
Cardinal Health spies opportunity in Sichuan [Published CHINAdaily - May 21 2013]

More Content

All (825) | News (554) | Reports (18) | Blogs (150) | Audio/Video (2) | Fact Sheets (3) | Press Releases (98)
sort by: Date | Relevance
Amniotic Membrane For Ocular Inflammation [Published Ophthalmology Management - 9 mins ago]
Should These Drug Companies Pay a Dividend? [Published Motley Fool - 41 mins ago]
Quinn Clinics Among First in UK to Offer New Ju... [Published PRWeb UK - 5 hours ago]
Research and Markets Adds Report: Allergan Part... [Published Individual.com - 13 hours ago]
Mill Creek Residential Breaks Ground on Three M... [Published Equities.com - 17 hours ago]
Pro Te Solutio - Vol. 6 No. 1 February 2013 [Published JD Supra - May 22 2013]
Colorescience Appoints Steve Loomis Chief Finan... [Published TickerTech.com - May 22 2013]
Colorescience Appoints Steve Loomis Chief Finan... [Published KCTV 5 - May 22 2013]
Allergan (AGN) Showing Bearish Technicals But C... [Published MarketIntelligenceCenter.com - May 22 2013]
MediFocus: Medical Devices for the Treatment of... [Published companiesandmarkets.com - May 22 2013]
Botox – Is the World’s Most Popular Cosmetic Pr... [Published Bio-Medicine - May 21 2013]
Susan G. Komen Orange County’s Pink Tie Ball Ra... [Published Prlog - May 21 2013]
Botox – Is the World’s Most Popular Cosmetic Pr... [Published Digital Journal - May 21 2013]
Top 10 Biotech CEO Pay Packages of 2012 [Published FierceBiotech - May 21 2013]
Local Doctors Get Big Bucks from Big Pharma [Published NBC Connecticut - May 21 2013]
News Review: Allergan, Inc. (NYSE:AGN), Infiner... [Published SBWire - May 21 2013]
Allergan, Mentor and Galderma Lead the Accelera... [Published PRWeb - May 21 2013]
Cardinal Health spies opportunity in Sichuan [Published CHINAdaily - May 21 2013]
Injectable Fillers - How to Avoid Nurse Injecto... [Published SBWire - May 20 2013]
Court Report -- May 19, 2013 [Published JD Supra - May 20 2013]
ACADIA Pharmaceuticals Announces Exercise in Fu... [Published Business Wire - May 20 2013]
PCA SKIN Announces New Executive Leadership as ... [Published TickerTech.com - May 20 2013]
Shares of Allergan Under Pressure, Down 1.5% [Published Individual.com - May 20 2013]
Innovation Leader NineSigma Announces Strong Gl... [Published Market Wire - May 20 2013]
Allergan Stock To Go Ex-dividend Tomorrow (AGN) [Published Philadelphia Inquirer - May 20 2013]
Allergan, Inc. (AGN) Ex-Dividend Date Scheduled... [Published Nasdaq - May 20 2013]
ACADIA Pharmaceuticals Added to NASDAQ Biotechn... [Published StockHouse USA - May 20 2013]
New DPCO may hit the prospects of MNCs, may for... [Published PharmaBiz - May 20 2013]
Overseas Stocks - May 20 [Published Trading Room - May 19 2013]
Se Acelera el Impulso de DocuSign ya que Más Em... [Published HP Developer's Journal - May 18 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
David E I Pyott, Jim Cramer, Jeff Edwards, [more]
  •  
MAP Pharmaceuticals Inc, New York Stock Exchange, SkinMedica Inc, [more]
  •  
FDA Food & Drug Administration, Environmental Defense, Federal Trade Commission, [more]
  •  
Megrim, Drugs, Obesity, [more]
  •  
LEVADEX, Botox, Eylea, [more]
  •  
Chicago, Dublin, Mountain View (California, United States), [more]
  •  
United States, South Africa, India, [more]
  •  
Medicine, Biology, Biotechnology, [more]
  •  
Pharma & Biotech, Health, Banking & Financial Services, [more]
MarketIntelligenceCenter.com, Street Insider, DailyMed Drug Label Updates for the last seven ..., [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Allergan (AGN) Showing Bearish Technicals But C... [Published MarketIntelligenceCenter.com - May 22 2013]
Allergan Inc. (NYSE: AGN) closed Tuesday's trading session at $98.54. In the past year, the stock has hit a 52-week low of $81.28 and 52-week high of $116.45. Allergan (AGN) stock has been showing support around $96.89 and resistance in the $100.47 range. ...
Allergan (AGN) Showing Bearish Technicals With ... [Published MarketIntelligenceCenter.com - May 16 2013]
Allergan Inc. (NYSE: AGN) closed Wednesday's trading session at $102.82. In the past year, the stock has hit a 52-week low of $81.28 and 52-week high of $116.45. Allergan (AGN) stock has been showing support around $101.85 and resistance in the $104.55 ...
SKINMEDICA ENVIRONMENTAL DEFENSE SUNSCREEN SPF ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Updated Date: May 8, 2013 EST ...
Allergan (AGN) Could Fall Through $101.96 Suppo... [Published MarketIntelligenceCenter.com - May 10 2013]
Allergan Inc. (NYSE: AGN) closed Thursday's trading session at $103.15. In the past year, the stock has hit a 52-week low of $81.28 and 52-week high of $116.45. Allergan (AGN) stock has been showing support around $101.96 and resistance in the $104.90 ...
SKINMEDICA ENVIRONMENTAL DEFENSE SUNSCREEN SPF ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Updated Date: May 8, 2013 EST ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Mad Money Uncovered: Allergan [Published TheStreet.com - YouTube - May 08 2013]
Alternative Gift for Valentines: Aesthetic Medi... [Published ABN Digital - Video - Feb 14 2013]
1

Press Releases

sort by: Date | Relevance
ACADIA Pharmaceuticals Announces Exercise in Fu... [Published Business Wire - May 20 2013]
DocuSign Momentum gewinnt mit Keep Business Dig... [Published PR inside - May 18 2013]
Research and Markets: Allergan Partnering 2005-... [Published Business Wire - May 17 2013]
Research and Markets: Allergan Partnering 2005-... [Published Business Wire Professional Services News - May 17 2013]
Michael Patrick Partners Celebrates its 30-Year... [Published Business Wire - May 14 2013]
1 2 3 4 5 6 7 8 9 10 ...
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.